FDA Inspection 1136685 — Neogen Corporation

Neogen Corporation — FEI 3009631819

The FDA completed an inspection of Neogen Corporation on March 16, 2021 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2021
Fiscal Year
2021
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Lexington, KY (United States)

Citations

IDCFRDescription
150521 CFR 211.122(d)Label storage access limited to authorized personnel
150621 CFR 211.122(e)Destruction of obsolete labeling
191221 CFR 211.166(a)Written program not followed
240121 CFR 211.194(a)(4)Complete Test Data
434221 CFR 211.142(b)Storage under appropriate conditions